Skip to main content
. 2016 Jun 16;12(19):2205–2214. doi: 10.2217/fon-2016-0046

Table 1. . Tumor and demographic characteristics of patients with melanoma.

Variables (n = 644 unless otherwise specified) n (%) or mean ± SD (range)
Age (years)
60.94 ± 15.59 (range: 11–96)
Gender:  
– Male 390 (60)
– Female
254 (40)
TNM classification/stage:  
– T0N0M0 92 (14)
– T1N0M0 166 (26)
– T2N0M0 273 (42)
– T3 (any T, N1+, M0) 82 (13)
– T4 (any T, any N, M1+)
31 (5)
Current status (n = 576):  
– Alive 449 (78)
– Deceased
127 (22)
Cancer status (n = 576):  
– No evidence of cancer 473 (73)
– Evidence of cancer 102 (16)
– Unknown
1 (0.2)
Histologic subtype:  
– Malignant melanoma NOS 527 (82)
– Melanoma in situ 89 (14)
– Desmoplastic 16 (3)
– Superficial spreading 6 (0.9)
– Spindle cell 3 (0.5)
– Malignant melanoma in giant pigmented nevus 2 (0.3)
– Nodular
1 (0.2)
Site:  
– Head and neck: 191 (30)
• Face/ears 31 (5)
• Other and unspecified parts of face 83 (13)
• Scalp/neck 78 (12)
– Trunk 159 (25)
– Upper limb and shoulder 154 (24)
– Lower limb and hip 113 (18)
– NOS/overlapping
27 (4)
Breslow thickness (mm) (n = 490)
2.02 ± 2.05 (range: 0–9.80)
Serum albumin (g/dl) (n = 564)
4.13 ± 0.35 (range: 2.5–5.1)
Serum total calcium (mg/dl) (n = 644)
9.46 ± 0.50 (range: 7.20–11.30)
Serum albumin-corrected calcium (mg/dl) (n = 564) 9.55 ± 0.44 (range: 8.20–11.70)

NOS: Not otherwise specified; SD: Standard deviation.